CEO and President Pablo J Cagnoni sold $44K of Rubius Therapeutics, Inc.

Sold$44,236

$6.57Price

6,730Shares

−16%Stake

What RUBY did after the filing

Prices for RUBY after this filing aren't in yet.

Traded Tue, Feb 1. Filed Tue, Feb 1, 9:20 PM ET, after the close. Not investment advice.